logo
Gastrointestinal cancers are rising dramatically in people under 50

Gastrointestinal cancers are rising dramatically in people under 50

NBC News6 days ago
Gastrointestinal cancers, which include colorectal, stomach and pancreatic cancer, are rising dramatically in younger adults, though doctors aren't fully sure why. Even some of the possible causes require more research, they say.
According to a review published Thursday in JAMA, gastrointestinal cancers have become the fastest-growing type of cancers diagnosed in adults younger than 50 in the U.S.
The review, one of the most comprehensive looks at gastrointestinal cancer trends, summarized the findings of major international and U.S. cancer databases, plus 115 papers on gastrointestinal cancers published from January 2014 to March 2025.
The authors underscore the need for people to follow the screening guidelines for colorectal cancer, which suggest that people with an average risk start screening — usually a colonoscopy or stool test — at age 45. Since doctors don't routinely screen for pancreatic, stomach and esophageal cancers in the U.S., the authors also call for new ways to screen more people for these cancers.
'This really points to the importance of trying to improve screening and early detection,' said Dr. Kimmie Ng, the review's co-author and director of the Young-Onset Colorectal Cancer Center at Dana-Farber Cancer Institute.
According to the review, colorectal cancer is by far the most common early-onset gastrointestinal cancer, with nearly 185,000 cases reported worldwide in 2022 and nearly 21,000 cases reported that same year in the U.S. Diagnoses in the U.S. have risen 2% annually in people younger than 50 since 2011, according to the American Cancer Society.
'It never used to happen in this age group, and now a very significant rise in 20-, 30- and 40-year-olds are getting colon cancer,' said Dr. John Marshall, chief medical consultant at the nonprofit Colorectal Cancer Alliance, who was not involved in the research. In one of the most high-profile examples, actor Chadwick Boseman was diagnosed with colon cancer in 2016 and died of the disease four years later at age 43.
Early-onset cases of pancreatic, stomach and esophageal cancers are also rising, according to the new study. Previous research has shown a disproportionate share of those gastrointestinal cancer diagnoses were among Black and Hispanic people. Pancreatic cancer is among the deadliest forms of cancer, with just 13% of patients surviving five years after their diagnosis.
Because colorectal cancer is the most common, doctors said they have a better grasp of what might be contributing to these early-onset cases compared with others.
'If we can understand what's going on in colorectal [cancer], I think it would really provide a lot of guidance to help us understand the other GI tract cancers,' said Dr. Scott Kopetz, a professor of gastrointestinal medical oncology at the University of Texas MD Anderson Cancer Center.
Kopetz said there are likely multiple factors driving the increase in early-onset cases.
'The leading theory is that there is no single leading theory,' he said.
Ng's new review in JAMA suggests that most gastrointestinal cancers in people under 50 are associated with lifestyle factors such as obesity, lack of exercise, poor diet, cigarette smoking or alcohol consumption. One study included in the review found that women who consumed more sugar-sweetened beverages during adolescence had a higher risk of developing early-onset colorectal cancer.
'It's really what people were doing or exposed to when they were infants, children, adolescents that is probably contributing to their risk of developing cancer as a young adult,' Ng said.
Health Secretary Robert F. Kennedy Jr. has been vocal about the association between sugary beverages and health issues, including cancer. On Wednesday, President Donald Trump said Coca-Cola will start being made with cane sugar rather than corn syrup in the U.S., but the company did not commit to the change when asked about it by NBC News.
Marshall said he suspects the rise in early-onset colorectal cancer could have something to do with changes in people's gut microbiomes — the bacteria that live in our gastrointestinal tracts. Diet, antibiotic use, microplastics and exposure to environmental chemicals likely all influence a person's gut bacteria, but scientists still don't have a clear understanding of what a healthy microbiome looks like nor how it affects our health. That is a booming area of research.
Ng's review also found that 15% to 30% of people with early-onset gastrointestinal cancer carry hereditary genetic mutations that may have predisposed them to getting cancer at a young age. Because of that, she said, 'we do recommend that all young patients diagnosed under the age of 50 undergo testing for hereditary conditions.'
Overall survival rates for gastrointestinal cancers have gotten better over time, due to improvements in treatment and screening. But Ng's review found that younger patients often have worse outcomes, despite typically receiving more treatments, including more surgery, radiation and aggressive combinations of chemotherapy, she said.
One reason could be that primary care doctors may overlook symptoms such as abdominal pain, constipation, heartburn or reflux in younger patients, thereby delaying their diagnoses.
'My personal feeling is that it's because we're finding them at a more advanced stage, because people don't really think of colon or other GI cancers when they see a young person with these nonspecific complaints,' said Dr. Howard Hochster, director of gastrointestinal oncology at Rutgers Cancer Institute and RWJBarnabas Health in New Jersey.
But Ng said that even after controlling for the stage at which patients are diagnosed, young people still seem to have worse survival rates.
'This makes us wonder as researchers whether that means that the cancers that develop in younger people may be biologically different and more aggressive, or maybe less responsive to treatment,' she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'I was failed because I wasn't seen as an individual': Black mother shares maternity failure
'I was failed because I wasn't seen as an individual': Black mother shares maternity failure

ITV News

time2 days ago

  • ITV News

'I was failed because I wasn't seen as an individual': Black mother shares maternity failure

A black mother of two has told ITV News that she was failed by her doctors during her first birth - an experience she believes put her life in danger. Sarah Tade, 34, who is also a GP clinician, gave birth to her first son Micah in 2022, but has since shared the trauma she experienced during labour. She described how her cries of pain were ignored by healthcare professionals and told ITV News she "wasn't seen as an individual". Ms Tade believes her race and gender contributed to her mistreatment. "My voice was ignored. If you recognise someone as an individual, you listen to their voice." Sarah Tade gave birth to her first son Micah in 2022, but said she was ignored during labour This comes as new data reveals that half of Black women face barriers in maternity care. The charity Five X More surveyed more than 1,100 Black women and found 28% reported discrimination during maternity care. 25% believe this is down to racial prejudice. 45% say they raised concerns during labour or birth; of these 49% felt their concerns were not properly addressed. After a failed labour induction, Ms Tade's waters broke 'spontaneously' whilst still in hospital. She says that's when it all went wrong. The battle was not giving birth but convincing her clinicians that she was, in fact, in labour. 'I asked for pain relief, the one that was prescribed, and it wasn't given to me. I was told you already had it, even though that was four hours ago, so there was literally nothing in my system by the time it was the onset of labour. 'As the pain got worse, I wasn't coping. I said I need my epidural please, because this was a part of my birth plan. Again, that was ignored.' Ms Tade said there was "no empathy" for her and that she was not only not given medication for her pain, but also was taken off gas and air. "How can you leave a pregnant woman going into labour in pain? It was horrendous.' Ms Tade said it only after she alerted them to the fact that she is a qualified GP that her treatment changed When she felt her water breaking, she told ITV News: 'I was again dismissed and not examined and told it was moisture. As a clinician, I began to grow very concerned.' It was only after she alerted them to the fact that she is a qualified GP that her treatment changed. 'When women say they are in pain, unfortunately, all of the data shows they are not believed. This isn't just in maternal health but throughout medicine. In my case, race... so now I'm a Black woman, which puts me further down the pecking order of being listened to and being believed.' Michelle Peter, co-author of the Five X More report, said: 'We also see this element of racism, whether it's overt and explicit or more subtle and implicit and structural in nature. 'It's this additional unique experience that Black women face, this racialisation of their care, the racist comments that are explicitly made sometimes. 'It makes it really difficult for us to deny any racial aspect of their care.' She goes on to give examples of explicit comments made to some of the women she's spoken to – including one who was told 'thank goodness you got that monkey out of you.'

Charities call for 'vital changes' as Lupita Nyong'o details decade-long health battle
Charities call for 'vital changes' as Lupita Nyong'o details decade-long health battle

Daily Mirror

time2 days ago

  • Daily Mirror

Charities call for 'vital changes' as Lupita Nyong'o details decade-long health battle

Lupita Nyong'o speaks out about her uterine fibroids, urging women to not stay silent, whilst charities are calling for significant changes on women's reproductive health Lupita Nyong'o candidly shared the details of her decade-long journey with uterine fibroids since her diagnosis in March 2014. ‌ The US actor said she had been secretly battling the condition, which are non-cancerous growths that develop in or around the womb, for a decade. ‌ In a post shared on her Instagram page, Lupita, 42, said she was "speaking up" about her story. Along with a series of snaps, she said she hoped her experience would "resonate with anyone else who has ever felt dismissed, confused or alone". ‌ "And I hope to seek answers for the far too many women dealing with uterine fibroids (80% of Black women and 70% of white women by age 50!). We deserve better. It's time to demand it. Silence serves no one," she wrote. Uterine fibroids are non-cancerous growths developing in and around the womb. Statistics show that 2 in 3 women, most commonly between the ages of 30-50, will get a fibroid in their lifetime. 80% of Black women and 70% of white women by the age of 50 will get a fibroid. ‌ The symptoms of the fibroids vary from; heavy menstrual bleeding and anaemia, pelvic pain, pregnancy complications and frequent urination, whilst others may not have any symptoms. Women's health charity, Wellbeing of Women, revealed how "fantastic" it was for Lupita to have spoken out about her uterine fibroids as their Just a Period campaign has called for urgent change in this area. For more stories like this subscribe to our weekly newsletter, The Weekly Gulp, for a curated roundup of trending stories, poignant interviews, and viral lifestyle picks from The Mirror's Audience U35 team delivered straight to your inbox. ‌ "We want to see an end to the shame, stigma and silence around heavy bleeding and pain," Marianne Sladowsky, head of communications and campaigns said. "[We want] more education for young people so that girls are able to know when they need to seek help for their periods, better education for GPs to end the dismissal that many women encounter when they seek help and more money to fund women's health research so that we are better able to diagnose and treat women's health problems." When asked about the state of women's health, head of communications at Endometriosis UK, Faye Farthing, said women's health has been "under-prioritised and under-funded for too long". ‌ "It's time the tide changed to ensure that everyone experiencing symptoms of a menstrual health condition receives the right care at the right time," she told The Mirror. "Without vital changes to education, health and employment - those with the disease [endometriosis] will continue to suffer. We hope that this [UK] Government prioritises women's health and ensures that there is the necessary funding, capacity and resources to meet the needs of patients so that everyone gets access to the right care at the right time." Help us improve our content by completing the survey below. We'd love to hear from you!

A genetic test could predict the odds of obesity, allowing for early interventions
A genetic test could predict the odds of obesity, allowing for early interventions

NBC News

time2 days ago

  • NBC News

A genetic test could predict the odds of obesity, allowing for early interventions

A genetic test may one day predict a child's risk of obesity in adulthood, paving the way for early interventions. Certain genetic variants can affect how a person's body stores fat or make them more prone to overeating. Genetic variation can also predict how well a person will respond to different weight loss drugs. In a study published Monday in the journal Nature Medicine, more than 600 researchers from around the world worked together to compile genetic data from more than 5 million people — the largest and most diverse genetic dataset to date. They also used genetic data from 23andMe. From the dataset, the researchers were able to create what's known as a polygenic risk score, which takes into account which genetic variants a person has that have been linked to a higher BMI in adulthood. The score, the researchers said, could be used to predict a person's risk of obesity as an adult — before they even turn 5. 'Childhood is the best time to intervene,' said study co-author Ruth Loos, a professor at the University of Copenhagen's Novo Nordisk Foundation Center for Basic Metabolic Research. (Research conducted at the center is not influenced by drugmaker Novo Nordisk, though some of the study authors had ties to pharmaceutical companies that make weight loss drugs.) The findings come as obesity is rising around the world. Rates of obesity in adults have more than doubled globally since 1990, and adolescent rates have quadrupled, according to the World Health Organization. About 16% of adults worldwide have obesity and the situation is worse in the United States, where more than 40% of adults have obesity, Centers for Disease Control and Prevention statistics show. Twice as effective The new test is not the first that predicts a person's risk of obesity, but Loos and her team showed it was about twice as effective as the method doctors currently use to assess their patients. That polygenetic score can account for about 8.5% of a person's risk for having a high BMI as an adult. The new score increased that to about 17.6%, at least in people with European ancestry. 'That's a pretty powerful risk indicator for obesity, but it still leaves open a lot that is unknown,' said Dr. Roy Kim, a pediatric endocrinologist at Cleveland Clinic Children's who was not involved with the research. Based on this score, more than 80% of a person's risk for obesity can be explained by other factors, such as where they live, what kinds of foods they have access to, and how much they exercise. The test was not nearly as effective in predicting obesity risk in non-Europeans. It explained about 16% of the risk for having a high BMI in East Asian Americans, but just 2.2% in rural Ugandans. About 70% of people whose data was included in the study were of predominantly European ancestry. About 14% were Hispanic and typically had a mix of ancestries. About 8% were of predominantly East Asian descent and just under 5% were of predominantly African ancestry. These samples were predominantly from African American people, who largely had mixed ancestry. Just 1.5% were of predominantly South Asian ancestry. Loos said the new score is a big step forward, but that it's still a prototype. The next step is to collect more — and more diverse — data on people with African ancestry in particular to improve how well the score works for everyone, not just white people. She said the score could offer one indicator — what high blood pressure is to heart disease, for example — that could help predict a person's risk of developing obesity. 'Obesity is not only about genetics, so genetics alone can never accurately predict obesity,' Loos said. 'For the general obesity that we see all over the world, we need other factors such as lifestyle that need to be part of the predictions.' Genetics play a bigger role in severe obesity, meaning a BMI of more than 40, she added. Still, identifying a person's genetic risk early on in childhood and intervening early with lifestyle coaching could make a big difference, she said. Research has shown that about 55% of children with obesity go on to have obesity in adolescence, and that about 80% of those individuals will have obesity in adulthood. 'Behavioral things are really important,' Kim said. 'Their environment, their access to healthy food, exercise opportunities, even their knowledge about healthy foods all affect a person's obesity risk.' How important are genetics, really? Although studies in identical twins have found that genetics can account for as much as 80% of the reason a person has obesity, lifestyle factors still play a huge role, Kim said. 'Even with the same genetic makeup, people can have different body types,' he said. 'From a very young age in my practice, we educate patients about the importance of eating protein-rich foods, a lot of fruits and vegetables and not too many refined carbs.' Dr. Juliana Simonetti, co-director of the Comprehensive Weight Management Program at the University of Utah, has been using genetic testing in her adult patients for about five years. She said understanding a person's genes can help doctors better treat weight gain. 'Obesity is not homogeneous. We have different kinds and different presentations,' said Simonetti, who wasn't involved with the new study. Simonetti uses a person's genes to determine if a patient struggles with satiety, or feeling full. 'They eat but do not feel full,' Simonetti said, adding that this is a disorder caused by genetic mutations affecting certain pathways in the body. People who have these mutations 'tend to have higher weight,' she said. But such mutations do not tell the whole genetic story of obesity, Simonetti said. The genes that a person inherits from either parent, even if they are not mutations, also determine how a person's body stores weight or uses energy. Both can play a big role in obesity risk. Genetic testing is also starting to be able to determine how well certain weight loss drugs will work for a person, Simonetti said, but she added this is just the beginning. 'We are talking about three out of 80 mutations that we can treat,' she said. 'We are getting better, and the more data we have, I'm hopeful that we are going to do a better job in being more precise in understanding treatment responses.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store